PMID- 17994224 OWN - NLM STAT- MEDLINE DCOM- 20080118 LR - 20160512 IS - 1618-2650 (Electronic) IS - 1618-2642 (Linking) VI - 390 IP - 2 DP - 2008 Jan TI - Profiling of 3,4-methylenedioxymethamphetamine by means of high-performance liquid chromatography. PG - 715-22 AB - An impurity-profiling method for 3,4-methylenedioxymethamphetamine (MDMA) is presented. The impurities of interest were extracted by solid-phase extraction (SPE) on Bakerbond C18 spe columns from a weakly alkaline solution (pH 8.5). Development of the extraction conditions covered selection of the buffer for dissolution of the sample and the volume of the eluent used to elute the impurities. An important part of the studies was to optimise the separation conditions, and the simplex method was used for this purpose. Cluster analysis was applied for comparison of samples and its grouping. The developed method was based on the areas of 33 selected peaks corresponding to MDMA impurities. All examined samples were correctly classified into clusters corresponding to the synthetic route. FAU - Byrska, Bogumila AU - Byrska B AD - Institute of Forensic Research, Westerplatte 9, 31 033, Krakow, Poland. FAU - Zuba, Dariusz AU - Zuba D LA - eng PT - Journal Article DEP - 20071110 PL - Germany TA - Anal Bioanal Chem JT - Analytical and bioanalytical chemistry JID - 101134327 RN - 4764-17-4 (3,4-Methylenedioxyamphetamine) SB - IM MH - 3,4-Methylenedioxyamphetamine/*analysis MH - Chromatography, High Pressure Liquid/*instrumentation/*methods MH - Hydrogen-Ion Concentration EDAT- 2007/11/13 09:00 MHDA- 2008/01/19 09:00 CRDT- 2007/11/13 09:00 PHST- 2007/09/12 00:00 [received] PHST- 2007/10/16 00:00 [accepted] PHST- 2007/10/08 00:00 [revised] PHST- 2007/11/13 09:00 [pubmed] PHST- 2008/01/19 09:00 [medline] PHST- 2007/11/13 09:00 [entrez] AID - 10.1007/s00216-007-1709-x [doi] PST - ppublish SO - Anal Bioanal Chem. 2008 Jan;390(2):715-22. doi: 10.1007/s00216-007-1709-x. Epub 2007 Nov 10.